UB Paderborn / Katalog / Suche / in CDI

Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer

The New England journal of medicine, 2002-10, Vol.347 (16), p.1233-1241

2002

Volltextzugriff (PDF)

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

JNCI : Journal of the National Cancer Institute, 2005-11, Vol.97 (22), p.1652-1662

2005

Volltextzugriff (PDF)

Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less

Journal of clinical oncology, 2002-10, Vol.20 (20), p.4141-4149

2002

Volltextzugriff (PDF)

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

The Lancet (British edition), 1999-06, Vol.353 (9169), p.1993-2000

1999

Volltextzugriff (PDF)

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2672-2685

1998

Volltextzugriff (PDF)

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2483-2493

1997

Volltextzugriff (PDF)

Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23

Journal of clinical oncology, 2001-02, Vol.19 (4), p.931-942

2001

Volltextzugriff (PDF)

Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer

JNCI : Journal of the National Cancer Institute, 1997-11, Vol.89 (22), p.1673-1682

1997

Volltextzugriff (PDF)

Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors

JNCI : Journal of the National Cancer Institute, 1996-11, Vol.88 (21), p.1529-1542

1996

Volltextzugriff (PDF)

Abstract S6-04: Patient-reported outcome (PRO) results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) vs tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S6-S6-04

2016

Volltextzugriff (PDF)

PD07-08: The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy: NSABP Protocol B-40

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.PD07-08-PD07-08

2011

Volltextzugriff (PDF)

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil

Journal of clinical oncology, 1996-07, Vol.14 (7), p.1982-1992

1996

Volltextzugriff (PDF)

Ambulatory surgery for breast cancer patients

Annals of surgical oncology, 2000-04, Vol.7 (3), p.181-187

2000

Volltextzugriff (PDF)

Long-term tamoxifen citrate use and potential ocular toxicity

American journal of ophthalmology, 1998-04, Vol.125 (4), p.493-501

1998

Volltextzugriff (PDF)

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16

Journal of clinical oncology, 1990-06, Vol.8 (6), p.1005-1018

1990

Volltextzugriff (PDF)

SURGICAL CONSIDERATIONS FOR INVASIVE BREAST CANCER

The Surgical clinics of North America, 1999-10, Vol.79 (5), p.1031-1046

Margolese, Richard G.

1999

Volltextzugriff (PDF)

How do we interpret the results of the Breast Cancer Prevention trial?

Canadian Medical Association journal (CMAJ), 1998-06, Vol.158 (12), p.1613

Margolese, R G

1998

Volltextzugriff (PDF)

Fear of recurrence, breast‐conserving surgery, and the trade‐off hypothesis

Cancer, 1992-04, Vol.69 (8), p.2111-2115

1992

Volltextzugriff (PDF)

Surgical considerations in preoperative chemotherapy of breast cancer

Recent results in cancer research, 1998, Vol.152, p.193

Margolese, R G

1998

Volltextzugriff (PDF)

Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer

The New England journal of medicine, 1984-05, Vol.310 (21), p.1363

1984

Volltextzugriff (PDF)

Natural Killer Cell Function in Patients With Acquired Immunodeficiency Syndrome and Related Diseases

Journal of leukocyte biology, 1989-07, Vol.46 (1), p.75-83

1989

Volltextzugriff (PDF)

Presence of somatomedin receptors on primary human breast and colon carcinomas

Cancer letters, 1987-12, Vol.38 (1), p.223-230

1987

Volltextzugriff (PDF)

Breast cancer surgery: who chooses and how?

Canadian Medical Association journal (CMAJ), 1994-02, Vol.150 (3), p.331

Margolese, R G

1994

Volltextzugriff (PDF)

Axillary surgery in breast cancer—there still is a debate

European journal of cancer (1990), 1993, Vol.29 (6), p.801-801

Margolese, R.G.

1993

Volltextzugriff (PDF)

The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer

Cancer, 1991-08, Vol.68 (3), p.482-488

1991

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23

Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer

Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors

Abstract S6-04: Patient-reported outcome (PRO) results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) vs tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy

PD07-08: The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy: NSABP Protocol B-40

Ambulatory surgery for breast cancer patients

Long-term tamoxifen citrate use and potential ocular toxicity

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16

SURGICAL CONSIDERATIONS FOR INVASIVE BREAST CANCER

How do we interpret the results of the Breast Cancer Prevention trial?

Fear of recurrence, breast‐conserving surgery, and the trade‐off hypothesis

Surgical considerations in preoperative chemotherapy of breast cancer

Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer

Natural Killer Cell Function in Patients With Acquired Immunodeficiency Syndrome and Related Diseases

Presence of somatomedin receptors on primary human breast and colon carcinomas

Breast cancer surgery: who chooses and how?

Axillary surgery in breast cancer—there still is a debate

The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer

Suchergebnisse filtern